Renal cell carcinoma of native kidneys in renal transplant patients

Current Opinion in Urology

Volumn 21, Issue 5, 2011, Pages 376-379

  Klatte, Tobias ^a   Marberger, Michael ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Acquired cystic kidney disease; renal cyst; risk; screening; transplantation

Indexed keywords

EVEROLIMUS; IMMUNOSUPPRESSIVE AGENT; SORAFENIB; SUNITINIB; TEMSIROLIMUS;

AGE; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER RISK; CANCER SCREENING; CANCER SIZE; CANCER SURGERY; COMPUTER ASSISTED TOMOGRAPHY; DIALYSIS; DISEASE SEVERITY; ECHOGRAPHY; GENDER; GRAFT RECIPIENT; HEMATURIA; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY CARCINOMA; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; NEPHRECTOMY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RACE; REVIEW; SURGICAL PATIENT;

CARCINOMA, RENAL CELL; HUMANS; INCIDENCE; KIDNEY NEOPLASMS; KIDNEY TRANSPLANTATION; NEPHRECTOMY; PROGNOSIS; RISK FACTORS; SURGICAL PROCEDURES, MINIMALLY INVASIVE;

EID: 80051782755     PISSN: 09630643     EISSN: 14736586     Source Type: Journal    
DOI: 10.1097/MOU.0b013e32834962bf     Document Type: Review

References (31)

1. Weikert S, Ljungberg B. Contemporary epidemiology of renal cell carcinoma: perspectives of primary prevention. World J Urol 2010;28:247-252.
2. Ferlay J, Parkin DM, Steliarova-Foucher E. Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer 2010;46:765-781.
3. Kasiske BL, Snyder JJ, Gilbertson DT, Wang C. Cancer after kidney transplantation in the United States. Am J Transplant 2004;4:905-913. (Pubitemid 38745589)
4. Tsaur I, Obermuller N, Jonas D, et al. De novo renal cell carcinoma of native and graft kidneys in renal transplant recipients. BJU Int 2010; doi:10.1111/j.1464-410X.2010.09856.x.
5. Klatte T, Seitz C, Waldert M, et al. Features and outcomes of renal cell carcinoma of native kidneys in renal transplant recipients. BJU Int 2010;105:1260-1265.
6. di Capua Sacoto C, Lujan Marco S, Bahilo Mateu P, et al. [De novo urological neoplasms in kidney transplant patients: experience in 1, 751 patients]. Actas Urol Esp 2010;34:88-94.
7. Schwarz A, Vatandaslar S, Merkel S, Haller H. Renal cell carcinoma in transplant recipients with acquired cystic kidney disease. Clin J Am Soc Nephrol 2007;2:750-756. Large prospective series, screening recommendations.
8. Hurst FP, Jindal RM, Graham LJ, et al. Incidence, predictors, costs, and outcome of renal cell carcinoma after kidney transplantation: USRDS experience. Transplantation 2010;90:898-904. Large series on risk factors for RCC after renal transplantation.
9. Filocamo MT, Zanazzi M, Li Marzi V, et al. Renal cell carcinoma of native kidney after renal transplantation: clinical relevance of early detection. Transplant Proc 2009;41:4197-4201.
10. Tillou X, Demailly M, Hakami F, et al. De novo renal carcinoma in renal transplant recipients: effect of early treatment. Transplant Proc 2009;41:3314-3316.
11. Doublet JD, Peraldi MN, Gattegno B, et al. Renal cell carcinoma of native kidneys: prospective study of 129 renal transplant patients. J Urol 1997;158:42-44. (Pubitemid 27251590)
12. Goh A, Vathsala A. Native renal cysts and dialysis duration are risk factors for renal cell carcinoma in renal transplant recipients. Am J Transplant 2011;11:86-92.
13. Kim DY, Abouljoud M, Parasuraman R. The role of microscopic hematuria in the evaluation of urologic malignancy in renal transplant recipients. Transplant Proc 2010;42:1641-1642. Importance of microscopic hematuria in renal transplant recipients.
14. Chen CH, Wen MC, Wang M, et al. High incidence of malignancy in polyomavirus-associated nephropathy in renal transplant recipients. Transplant Proc 2010;42:817-818.
15. Fleming S. Renal cell carcinoma in acquired cystic kidney disease. Histopathology 2010;56:395-400.
16. Moch H. Cystic renal tumors: new entities and novel concepts. Adv Anat Pathol 2010;17:209-214.
17. Tickoo SK, dePeralta-Venturina MN, Harik LR, et al. Spectrum of epithelial neoplasms in end-stage renal disease: an experience from 66 tumor-bearing kidneys with emphasis on histologic patterns distinct from those in sporadic adult renal neoplasia. Am J Surg Pathol 2006;30:141-153. (Pubitemid 43740182)
18. Pan CC, Chen YJ, Chang LC, et al. Immunohistochemical and molecular genetic profiling of acquired cystic disease-associated renal cell carcinoma. Histopathology 2009;55:145-153.
19. Gobbo S, Eble JN, Grignon DJ, et al. Clear cell papillary renal cell carcinoma: a distinct histopathologic and molecular genetic entity. Am J Surg Pathol 2008;32:1239-1245.
20. Kuroda N, Shiotsu T, Kawada C et al. Clear cell papillary renal cell carcinoma and clear cell renal cell carcinoma arising in acquired cystic disease of the kidney: an immunohistochemical and genetic study. Ann Diagn Pathol 2010; doi:10.1016/j.anndiagpath.2010.03.007.
21. Klatte T, Said JW, Seligson DB, et al. Pathological, immunohistochemical and cytogenetic features of papillary renal cell carcinoma with clear cell features. J Urol 2011;185:30-35.
22. Kuntz E, Yusenko MV, Nagy A, Kovacs G. Oligoarray comparative genomic hybridization of renal cell tumors that developed in patients with acquired cystic renal disease. Hum Pathol 2010;41:1345-1349.
23. Klatte T, Rao PN, de Martino M, et al. Cytogenetic profile predicts prognosis of patients with clear cell renal cell carcinoma. J Clin Oncol 2009;27:746-753.
24. Greco F, Wagner S, Hoda MR et al. Single-Portal Access Laparoscopic Radical Nephrectomy for Renal Cell Carcinoma in Transplant Patients: the first experience. Eur Urol 2011;59:1060-1064. First report on single port laparoscopic nephrectomy for RCC in renal transplant recipients.
25. Tollefson MK, Krambeck AE, Leibovich BC, etal. Surgical treatment of renal cell carcinoma in the immunocompromised transplant patient. Urology 2010;75:1373-1377.
26. Neuzillet Y, Lay F, Luccioni A, et al. De novo renal cell carcinoma of native kidney in renal transplant recipients. Cancer 2005;103:251-257. (Pubitemid 40129283)
27. Manuelli M, De Luca L, Iaria G, et al. Conversion to rapamycin immunosuppression for malignancy after kidney transplantation. Transplant Proc 2010;42:1314-1316.
28. Ciuffreda L, Di Sanza C, Incani UC, Milella M. The mTOR pathway: a new target in cancer therapy. Curr Cancer Drug Targets 2010;10:484-495.
29. Taylor AJ, Cohen EP, Erickson SJ, et al. Renal imaging in long-term dialysis patients: a comparison of CT and sonography. AJR Am J Roentgenol 1989;153:765-767. (Pubitemid 19243779)
30. Scandling JD. Acquired cystic kidney disease and renal cell cancer after transplantation: time to rethink screening? Clin J Am Soc Nephrol 2007;2:621-622.
31. Graumann O, Osther SS, Osther PJs. Characterization of complex renal cysts: a critical evaluation of the Bosniak classification. Scand J Urol Nephrol 2011;45:84-90.